The weight loss journey has become more accessible with the introduction of GLP-1 weight loss pills, particularly Wegovy (semaglutide) and Foundayo (orforglipron). These medications offer an alternative to injectable weight loss treatments, providing a more convenient option for those who prefer oral medications.
Understanding Wegovy and Foundayo
Wegovy is an FDA-approved oral semaglutide medication designed for adults with overweight or obesity. It works by mimicking the glucagon-like peptide 1 (GLP-1) protein in the body, reducing hunger and slowing down food transit in the gut. The medication is taken once a day on an empty stomach with up to four ounces of water, and users must wait 30 minutes before eating or taking other oral medications.
Foundayo, on the other hand, is also a GLP-1 medication made by Lilly. It mimics the GLP-1 hormone released by the gut after eating, signaling the brain that it’s time to stop eating. Foundayo has a small molecule structure, allowing it to pass through the gut intact regardless of food intake or timing.
Efficacy of Wegovy and Foundayo
Both medications have undergone extensive clinical trials, demonstrating similar weight loss results. Lilly reported that adults taking the highest dose of Foundayo lost an average of 27 pounds or 12.4% of their body weight over 72 weeks. In contrast, the Wegovy website states that adults in one clinical trial lost an average of 33 pounds or about 14% of their body weight over a 64-week period.
A comparison of the two medications was conducted, but the results are complicated due to the indirect nature of the comparison. Novo Nordisk noted that people taking Wegovy had “significantly greater weight loss” than those taking Foundayo. However, this comparison was not a head-to-head randomized controlled trial, making it difficult to draw conclusions.
Practical Considerations
The main difference between Wegovy and Foundayo lies in their administration. Wegovy must be taken on an empty stomach with limited water intake, while Foundayo can be taken without any meaningful restrictions around meals or water. This flexibility may be beneficial for individuals with unpredictable schedules or those who struggle with adherence to complicated dosing rules.
Ultimately, the decision between Wegovy and Foundayo should be based on an honest conversation with a healthcare provider, taking into account individual goals and needs. As patients should do their own research while consulting their healthcare provider to ensure that the information is supported by scientific evidence.
Cost is a factor for many individuals considering GLP-1 medications, such as GLP-1 drug costs which can be a significant burden.
Individuals with depression may also benefit from exploring new treatments, such as those discussed in articles about depression and the search for new treatments, in conjunction with their weight loss journey.
